{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:24:51Z","timestamp":1794900291394,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010408","name":"Shared Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"Cancercare Manitoba Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ygyno.2021.02.038","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:52:20Z","timestamp":1615423940000},"page":"769-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples"],"prefix":"10.1016","volume":"161","author":[{"given":"Claire R.","family":"Morden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally C.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirka","family":"Sliwowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelda","family":"Lichtensztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon D.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Nachtigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.02.038_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","article-title":"Pathogenesis and heterogeneity of ovarian cancer","volume":"29","author":"Kroeger","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Coleman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-019-0484-6","article-title":"Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status","volume":"12","author":"Gadducci","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.hoc.2018.07.007","article-title":"Mechanisms of drug resistance in high-grade serous ovarian cancer","volume":"32","author":"Freimund","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0045","first-page":"371","article-title":"Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review","volume":"2019","author":"Binju","year":"1863","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.ygyno.2021.02.038_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tig.2007.11.006","article-title":"Defining \u2018chromosomal instability\u2019","volume":"24","author":"Geigl","year":"2008","journal-title":"Trends Genet"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020226","article-title":"Detecting chromosome instability in cancer: approaches to resolve cell-to-cell heterogeneity","volume":"11","author":"Lepage","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029611","article-title":"Chromosomal instability as a driver of tumor heterogeneity and evolution","volume":"7","author":"Bakhoum","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2018.08.021","article-title":"Chromosomal instability induces cellular invasion in epithelial tissues","volume":"47","author":"Benhra","year":"2018","journal-title":"Dev Cell"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","article-title":"Tumour heterogeneity and the evolution of polyclonal drug resistance","volume":"8","author":"Burrell","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/mutage\/gey016","article-title":"Geraniin selectively promotes cytostasis and apoptosis in human colorectal cancer cells by inducing catastrophic chromosomal instability","volume":"33","author":"Guo","year":"2018","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0085","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-10-3604","article-title":"Chromosomal instability confers intrinsic multidrug resistance","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0090","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1101\/gad.314351.118","article-title":"The impact of mitotic errors on cell proliferation and tumorigenesis","volume":"32","author":"Levine","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040824","article-title":"Chromosome instability; implications in cancer development, progression, and clinical outcomes","volume":"12","author":"Vishwakarma","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0100","doi-asserted-by":"crossref","first-page":"78234","DOI":"10.18632\/oncotarget.20829","article-title":"Chromosomal instability and acquired drug resistance in multiple myeloma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2021.02.038_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006707","article-title":"The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples","volume":"13","author":"Penner-Goeke","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neo.2015.02.001","article-title":"Characterizing the prevalence of chromosome instability in interval colorectal cancer","volume":"17","author":"Cisyk","year":"2015","journal-title":"Neoplasia."},{"key":"10.1016\/j.ygyno.2021.02.038_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123200","article-title":"A novel multiplexed, image-based approach to detect phenotypes that underlie chromosome instability in human cells","volume":"10","author":"Thompson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0120","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/nprot.2006.328","article-title":"Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients","volume":"1","author":"Shepherd","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1525-1438.2005.00150.x","article-title":"Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer","volume":"15","author":"Chen","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0135","first-page":"3325","article-title":"Contributions of ATM mutations to familial breast and ovarian cancer","volume":"63","author":"Thorstenson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/PAI.0b013e31827ea79e","article-title":"Pathways of colorectal Carcinogensis","volume":"21","author":"Arends","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0145","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","article-title":"Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma","volume":"80","author":"Geistlinger","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011408","article-title":"Copy number analysis identifies novel interactions between genomic loci in ovarian cancer","volume":"5","author":"Gorringe","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0155","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","article-title":"Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas","volume":"69","author":"Kuo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0165","first-page":"9","article-title":"Evolving therapeutic strategies to exploit chromosome instability in cancer","author":"Thompson","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrg1692","article-title":"The new cytogenetics: blurring the boundaries with molecular biology","volume":"6","author":"Speicher","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0175","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bies.201400218","article-title":"How to count chromosomes in a cell: an overview of current and novel technologies","volume":"37","author":"Bakker","year":"2015","journal-title":"Bioessays"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0180","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.celrep.2018.05.047","article-title":"Non-random mis-segregation of human chromosomes","volume":"23","author":"Worrall","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0185","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0190","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1038\/s41598-018-31097-y","article-title":"Evaluating tumor evolution via genomic profiling of individual tumor spheroids in a malignant ascites","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0195","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","article-title":"Copy number signatures and mutational processes in ovarian carcinoma","volume":"50","author":"Macintyre","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001789","article-title":"Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis","volume":"12","author":"Schwarz","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0205","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41467-020-14551-2","article-title":"A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity","volume":"11","author":"Nelson","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng.3573","article-title":"Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer","volume":"48","author":"McPherson","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbrc.2010.12.018","article-title":"Paclitaxel stimulates chromosomal fusion and instability in cells with dysfunctional telomeres: implication in multinucleation and chemosensitization","volume":"404","author":"Park","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2015.11.001","article-title":"Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer","volume":"53","author":"Lambrechts","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0225","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/01480545.2016.1252918","article-title":"Comparative study on the induction of complex genomic alterations after exposure of mammalian cells to carboplatin and oxaliplatin","volume":"40","author":"de Souza","year":"2017","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0230","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1158\/0008-5472.CAN-10-3667","article-title":"Paradoxical relationship between chromosomal instability and survival outcome in cancer","volume":"71","author":"Birkbak","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0235","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ijc.32729","article-title":"Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy","volume":"146","author":"Lee","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2020.11.051","article-title":"Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells","volume":"500","author":"Bungsy","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0245","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-021-01317-w","article-title":"Reduced SKP1 and CUL1 expression underlie increases in Cyclin E1 and chromosome instability in cellular predursors of high-grade se4rous ovarian cancer","author":"Lepage","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2021.02.038_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030531","article-title":"Reduced SKP1 expression induces chromosome instability through aberrant cyclin E1 protein turnover","volume":"12","author":"Thompson","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:48:20Z","timestamp":1715820500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821001992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0090825821001992"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}